Global Drug of Abuse Test (Saliva) Device Market Growth 2026-2032
The global Drug of Abuse Test (Saliva) Device market size is predicted to grow from US$ 174 million in 2025 to US$ 230 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Drug of Abuse Test (Saliva) Device refers to a category of on-site testing devices that use oral fluid or saliva specimens to rapidly screen or preliminarily identify drugs of abuse such as cannabinoids, amphetamines, opiates, cocaine and its metabolites, benzodiazepines, and methadone. Typical product forms include integrated oral fluid test cassettes, collection swabs, buffer systems, and in some cases matching reader terminals. These devices are generally based on colloidal gold or other lateral flow immunoassay technologies, and offer advantages such as non-invasive sampling, observed collection, convenient operation, and suitability for rapid field screening. They are widely used in law enforcement and roadside screening, workplace testing, judicial and forensic settings, rehabilitation programs, and selected medical support scenarios. Upstream raw materials mainly include antibodies, antigens and other bioactive materials, nitrocellulose membranes, colloidal gold or latex particles, plastic injection-molded parts, collection swabs, buffer solutions, and packaging materials. Downstream customers mainly include police and traffic enforcement agencies, third-party drug testing service providers, corporate pre-employment and workplace screening departments, judicial institutions, rehabilitation centers, and professional distributors. On an ex-factory basis, global nominal capacity for Drug of Abuse Test (Saliva) Devices is estimated at about 42.0 million units in 2025, with sales volume of about 30.16 million units, an average ex-factory price of about US$5.90 per unit, and an overall industry gross margin of around 44%-56%.
The market is still in a stage where rapid screening devices remain the mainstream, while more system-based solutions are gradually gaining traction. Drug of Abuse Test (Saliva) Devices continue to attract attention because they offer non-invasive sampling, observed collection, convenient on-site operation, and stronger relevance for identifying recent drug use. Compared with traditional urine-based methods, saliva devices are better suited for immediate screening and field decision-making, which supports their growing use in roadside enforcement, safety-sensitive job management, judicial support screening, and selected workplace testing scenarios. As a result, competition is no longer limited to the test device itself, but is expanding toward sampling experience, testing stability, result consistency, operational convenience, and service support.
From a product and competitive perspective, the market is still led by integrated rapid screening devices, supported by collection components, buffer systems, and in some cases reader-linked solutions. As customers place greater emphasis on compliance, standardization, and traceability, products relying only on visual interpretation are facing higher expectations for performance and workflow control. At the same time, solutions that can connect with reader devices, data recording functions, and confirmation processes are becoming more attractive. Industry competition is therefore shifting from single-product comparison to broader solution capability covering device design, collection support, interpretation, confirmation linkage, and training service.
Looking ahead, Drug of Abuse Test (Saliva) Devices are likely to move further toward multi-panel design, easier operation, more standardized results, and stronger system compatibility. As users gain more practical experience, market expectations will continue to rise for sensitivity, specificity, interference resistance, and specimen stability. At the same time, products that fit more smoothly into reader systems, data workflows, and laboratory confirmation processes are likely to gain stronger market acceptance. Customer demand will increasingly focus not only on whether a device can detect, but also on whether it can deliver accurate, stable, and well-controlled screening performance.
The main growth drivers include stronger compliance requirements, rigid risk-control needs in safety-sensitive sectors, rising employer attention to testing efficiency and specimen authenticity, and the continued need to upgrade screening tools as drug-use patterns become more complex. At the same time, the market also faces clear barriers, including regulatory differences across regions, high requirements for confirmation testing and procedural compliance in formal settings, long customer validation cycles, meaningful switching costs, and increasing expectations for result stability and workflow discipline. Overall, demand remains clear, but the industry threshold is rising from simple product supply toward broader capability in product performance, service execution, regulatory adaptation, and integrated delivery.
LP Information, Inc. (LPI) ' newest research report, the ?Drug of Abuse Test (Saliva) Device Industry Forecast? looks at past sales and reviews total world Drug of Abuse Test (Saliva) Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug of Abuse Test (Saliva) Device sales for 2026 through 2032. With Drug of Abuse Test (Saliva) Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug of Abuse Test (Saliva) Device industry.
This Insight Report provides a comprehensive analysis of the global Drug of Abuse Test (Saliva) Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug of Abuse Test (Saliva) Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug of Abuse Test (Saliva) Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug of Abuse Test (Saliva) Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug of Abuse Test (Saliva) Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug of Abuse Test (Saliva) Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drug of Abuse Test (Saliva) Device refers to a category of on-site testing devices that use oral fluid or saliva specimens to rapidly screen or preliminarily identify drugs of abuse such as cannabinoids, amphetamines, opiates, cocaine and its metabolites, benzodiazepines, and methadone. Typical product forms include integrated oral fluid test cassettes, collection swabs, buffer systems, and in some cases matching reader terminals. These devices are generally based on colloidal gold or other lateral flow immunoassay technologies, and offer advantages such as non-invasive sampling, observed collection, convenient operation, and suitability for rapid field screening. They are widely used in law enforcement and roadside screening, workplace testing, judicial and forensic settings, rehabilitation programs, and selected medical support scenarios. Upstream raw materials mainly include antibodies, antigens and other bioactive materials, nitrocellulose membranes, colloidal gold or latex particles, plastic injection-molded parts, collection swabs, buffer solutions, and packaging materials. Downstream customers mainly include police and traffic enforcement agencies, third-party drug testing service providers, corporate pre-employment and workplace screening departments, judicial institutions, rehabilitation centers, and professional distributors. On an ex-factory basis, global nominal capacity for Drug of Abuse Test (Saliva) Devices is estimated at about 42.0 million units in 2025, with sales volume of about 30.16 million units, an average ex-factory price of about US$5.90 per unit, and an overall industry gross margin of around 44%-56%.
The market is still in a stage where rapid screening devices remain the mainstream, while more system-based solutions are gradually gaining traction. Drug of Abuse Test (Saliva) Devices continue to attract attention because they offer non-invasive sampling, observed collection, convenient on-site operation, and stronger relevance for identifying recent drug use. Compared with traditional urine-based methods, saliva devices are better suited for immediate screening and field decision-making, which supports their growing use in roadside enforcement, safety-sensitive job management, judicial support screening, and selected workplace testing scenarios. As a result, competition is no longer limited to the test device itself, but is expanding toward sampling experience, testing stability, result consistency, operational convenience, and service support.
From a product and competitive perspective, the market is still led by integrated rapid screening devices, supported by collection components, buffer systems, and in some cases reader-linked solutions. As customers place greater emphasis on compliance, standardization, and traceability, products relying only on visual interpretation are facing higher expectations for performance and workflow control. At the same time, solutions that can connect with reader devices, data recording functions, and confirmation processes are becoming more attractive. Industry competition is therefore shifting from single-product comparison to broader solution capability covering device design, collection support, interpretation, confirmation linkage, and training service.
Looking ahead, Drug of Abuse Test (Saliva) Devices are likely to move further toward multi-panel design, easier operation, more standardized results, and stronger system compatibility. As users gain more practical experience, market expectations will continue to rise for sensitivity, specificity, interference resistance, and specimen stability. At the same time, products that fit more smoothly into reader systems, data workflows, and laboratory confirmation processes are likely to gain stronger market acceptance. Customer demand will increasingly focus not only on whether a device can detect, but also on whether it can deliver accurate, stable, and well-controlled screening performance.
The main growth drivers include stronger compliance requirements, rigid risk-control needs in safety-sensitive sectors, rising employer attention to testing efficiency and specimen authenticity, and the continued need to upgrade screening tools as drug-use patterns become more complex. At the same time, the market also faces clear barriers, including regulatory differences across regions, high requirements for confirmation testing and procedural compliance in formal settings, long customer validation cycles, meaningful switching costs, and increasing expectations for result stability and workflow discipline. Overall, demand remains clear, but the industry threshold is rising from simple product supply toward broader capability in product performance, service execution, regulatory adaptation, and integrated delivery.
LP Information, Inc. (LPI) ' newest research report, the ?Drug of Abuse Test (Saliva) Device Industry Forecast? looks at past sales and reviews total world Drug of Abuse Test (Saliva) Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug of Abuse Test (Saliva) Device sales for 2026 through 2032. With Drug of Abuse Test (Saliva) Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug of Abuse Test (Saliva) Device industry.
This Insight Report provides a comprehensive analysis of the global Drug of Abuse Test (Saliva) Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug of Abuse Test (Saliva) Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug of Abuse Test (Saliva) Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug of Abuse Test (Saliva) Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug of Abuse Test (Saliva) Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug of Abuse Test (Saliva) Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Consumables
- Equipment
- Online Sales
- Offline Sales
- Single-Panel
- Multi-Panel
- Traffic Safety & Roadside Testing
- Workplace Testing
- Healthcare & Rehabilitation
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Draeger
- Abbott Laboratories
- Securetec Detektions-Systeme
- Thermo Fisher Scientific
- Oranoxis
- Premier Biotech
- Healgen Scientific
- Lin-Zhi International
- Neogen Corporation
- UCP Biosciences
- American Screening Corp
- Randox Laboratories
- AccuBioTech
- Assure Tech (Hangzhou)
- Wondfo Biotech
- Hangzhou Biotest Biotech
- Dochekbio
- Venture Biotechnology
- Prometheus
- Core Technology
- Jiangsu Well Biotech Co., Ltd.
- Shanghai Chemtron Biotech
- Hangzhou Laihe Biotech
- What is the 10-year outlook for the global Drug of Abuse Test (Saliva) Device market?
- What factors are driving Drug of Abuse Test (Saliva) Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Drug of Abuse Test (Saliva) Device market opportunities vary by end market size?
- How does Drug of Abuse Test (Saliva) Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug of Abuse Test (Saliva) Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug of Abuse Test (Saliva) Device by Country/Region, 2021, 2025 & 2032
2.2 Drug of Abuse Test (Saliva) Device Segment by Type
2.2.1 Consumables
2.2.2 Equipment
2.2.3 Drug of Abuse Test (Saliva) Device Sales by Type
2.2.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Type (2021-2026)
2.3 Drug of Abuse Test (Saliva) Device Segment by Sales Channels
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Drug of Abuse Test (Saliva) Device Sales by Sales Channels
2.3.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels (2021-2026)
2.3.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Sales Channels (2021-2026)
2.3.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Sales Channels (2021-2026)
2.4 Drug of Abuse Test (Saliva) Device Segment by Testing Item
2.4.1 Single-Panel
2.4.2 Multi-Panel
2.4.3 Drug of Abuse Test (Saliva) Device Sales by Testing Item
2.4.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item (2021-2026)
2.4.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Testing Item (2021-2026)
2.4.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Testing Item (2021-2026)
2.5 Drug of Abuse Test (Saliva) Device Segment by Application
2.5.1 Traffic Safety & Roadside Testing
2.5.2 Workplace Testing
2.5.3 Healthcare & Rehabilitation
2.5.4 Others
2.5.5 Drug of Abuse Test (Saliva) Device Sales by Application
2.5.5.1 Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2021-2026)
2.5.5.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug of Abuse Test (Saliva) Device Breakdown Data by Company
3.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Company (2021-2026)
3.1.2 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company (2021-2026)
3.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Company (2021-2026)
3.2.1 Global Drug of Abuse Test (Saliva) Device Revenue by Company (2021-2026)
3.2.2 Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company (2021-2026)
3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Company
3.4 Key Manufacturers Drug of Abuse Test (Saliva) Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug of Abuse Test (Saliva) Device Product Location Distribution
3.4.2 Players Drug of Abuse Test (Saliva) Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG OF ABUSE TEST (SALIVA) DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Drug of Abuse Test (Saliva) Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug of Abuse Test (Saliva) Device Market Size by Country/Region (2021-2026)
4.2.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug of Abuse Test (Saliva) Device Sales Growth
4.4 APAC Drug of Abuse Test (Saliva) Device Sales Growth
4.5 Europe Drug of Abuse Test (Saliva) Device Sales Growth
4.6 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Growth
5 AMERICAS
5.1 Americas Drug of Abuse Test (Saliva) Device Sales by Country
5.1.1 Americas Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
5.1.2 Americas Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
5.2 Americas Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
5.3 Americas Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug of Abuse Test (Saliva) Device Sales by Region
6.1.1 APAC Drug of Abuse Test (Saliva) Device Sales by Region (2021-2026)
6.1.2 APAC Drug of Abuse Test (Saliva) Device Revenue by Region (2021-2026)
6.2 APAC Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
6.3 APAC Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug of Abuse Test (Saliva) Device by Country
7.1.1 Europe Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
7.1.2 Europe Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
7.2 Europe Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
7.3 Europe Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug of Abuse Test (Saliva) Device by Country
8.1.1 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
8.3 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug of Abuse Test (Saliva) Device
10.3 Manufacturing Process Analysis of Drug of Abuse Test (Saliva) Device
10.4 Industry Chain Structure of Drug of Abuse Test (Saliva) Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug of Abuse Test (Saliva) Device Distributors
11.3 Drug of Abuse Test (Saliva) Device Customer
12 WORLD FORECAST REVIEW FOR DRUG OF ABUSE TEST (SALIVA) DEVICE BY GEOGRAPHIC REGION
12.1 Global Drug of Abuse Test (Saliva) Device Market Size Forecast by Region
12.1.1 Global Drug of Abuse Test (Saliva) Device Forecast by Region (2027-2032)
12.1.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug of Abuse Test (Saliva) Device Forecast by Type (2027-2032)
12.7 Global Drug of Abuse Test (Saliva) Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Draeger
13.1.1 Draeger Company Information
13.1.2 Draeger Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.1.3 Draeger Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Draeger Main Business Overview
13.1.5 Draeger Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.2.3 Abbott Laboratories Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Securetec Detektions-Systeme
13.3.1 Securetec Detektions-Systeme Company Information
13.3.2 Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.3.3 Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Securetec Detektions-Systeme Main Business Overview
13.3.5 Securetec Detektions-Systeme Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Oranoxis
13.5.1 Oranoxis Company Information
13.5.2 Oranoxis Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.5.3 Oranoxis Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Oranoxis Main Business Overview
13.5.5 Oranoxis Latest Developments
13.6 Premier Biotech
13.6.1 Premier Biotech Company Information
13.6.2 Premier Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.6.3 Premier Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Premier Biotech Main Business Overview
13.6.5 Premier Biotech Latest Developments
13.7 Healgen Scientific
13.7.1 Healgen Scientific Company Information
13.7.2 Healgen Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.7.3 Healgen Scientific Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Healgen Scientific Main Business Overview
13.7.5 Healgen Scientific Latest Developments
13.8 Lin-Zhi International
13.8.1 Lin-Zhi International Company Information
13.8.2 Lin-Zhi International Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.8.3 Lin-Zhi International Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lin-Zhi International Main Business Overview
13.8.5 Lin-Zhi International Latest Developments
13.9 Neogen Corporation
13.9.1 Neogen Corporation Company Information
13.9.2 Neogen Corporation Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.9.3 Neogen Corporation Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Neogen Corporation Main Business Overview
13.9.5 Neogen Corporation Latest Developments
13.10 UCP Biosciences
13.10.1 UCP Biosciences Company Information
13.10.2 UCP Biosciences Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.10.3 UCP Biosciences Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 UCP Biosciences Main Business Overview
13.10.5 UCP Biosciences Latest Developments
13.11 American Screening Corp
13.11.1 American Screening Corp Company Information
13.11.2 American Screening Corp Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.11.3 American Screening Corp Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 American Screening Corp Main Business Overview
13.11.5 American Screening Corp Latest Developments
13.12 Randox Laboratories
13.12.1 Randox Laboratories Company Information
13.12.2 Randox Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.12.3 Randox Laboratories Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Randox Laboratories Main Business Overview
13.12.5 Randox Laboratories Latest Developments
13.13 AccuBioTech
13.13.1 AccuBioTech Company Information
13.13.2 AccuBioTech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.13.3 AccuBioTech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AccuBioTech Main Business Overview
13.13.5 AccuBioTech Latest Developments
13.14 Assure Tech (Hangzhou)
13.14.1 Assure Tech (Hangzhou) Company Information
13.14.2 Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.14.3 Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Assure Tech (Hangzhou) Main Business Overview
13.14.5 Assure Tech (Hangzhou) Latest Developments
13.15 Wondfo Biotech
13.15.1 Wondfo Biotech Company Information
13.15.2 Wondfo Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.15.3 Wondfo Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Wondfo Biotech Main Business Overview
13.15.5 Wondfo Biotech Latest Developments
13.16 Hangzhou Biotest Biotech
13.16.1 Hangzhou Biotest Biotech Company Information
13.16.2 Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.16.3 Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Hangzhou Biotest Biotech Main Business Overview
13.16.5 Hangzhou Biotest Biotech Latest Developments
13.17 Dochekbio
13.17.1 Dochekbio Company Information
13.17.2 Dochekbio Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.17.3 Dochekbio Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dochekbio Main Business Overview
13.17.5 Dochekbio Latest Developments
13.18 Venture Biotechnology
13.18.1 Venture Biotechnology Company Information
13.18.2 Venture Biotechnology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.18.3 Venture Biotechnology Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Venture Biotechnology Main Business Overview
13.18.5 Venture Biotechnology Latest Developments
13.19 Prometheus
13.19.1 Prometheus Company Information
13.19.2 Prometheus Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.19.3 Prometheus Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Prometheus Main Business Overview
13.19.5 Prometheus Latest Developments
13.20 Core Technology
13.20.1 Core Technology Company Information
13.20.2 Core Technology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.20.3 Core Technology Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Core Technology Main Business Overview
13.20.5 Core Technology Latest Developments
13.21 Jiangsu Well Biotech Co., Ltd.
13.21.1 Jiangsu Well Biotech Co., Ltd. Company Information
13.21.2 Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.21.3 Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Jiangsu Well Biotech Co., Ltd. Main Business Overview
13.21.5 Jiangsu Well Biotech Co., Ltd. Latest Developments
13.22 Shanghai Chemtron Biotech
13.22.1 Shanghai Chemtron Biotech Company Information
13.22.2 Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.22.3 Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Shanghai Chemtron Biotech Main Business Overview
13.22.5 Shanghai Chemtron Biotech Latest Developments
13.23 Hangzhou Laihe Biotech
13.23.1 Hangzhou Laihe Biotech Company Information
13.23.2 Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.23.3 Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Hangzhou Laihe Biotech Main Business Overview
13.23.5 Hangzhou Laihe Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug of Abuse Test (Saliva) Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug of Abuse Test (Saliva) Device by Country/Region, 2021, 2025 & 2032
2.2 Drug of Abuse Test (Saliva) Device Segment by Type
2.2.1 Consumables
2.2.2 Equipment
2.2.3 Drug of Abuse Test (Saliva) Device Sales by Type
2.2.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Type (2021-2026)
2.3 Drug of Abuse Test (Saliva) Device Segment by Sales Channels
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Drug of Abuse Test (Saliva) Device Sales by Sales Channels
2.3.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels (2021-2026)
2.3.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Sales Channels (2021-2026)
2.3.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Sales Channels (2021-2026)
2.4 Drug of Abuse Test (Saliva) Device Segment by Testing Item
2.4.1 Single-Panel
2.4.2 Multi-Panel
2.4.3 Drug of Abuse Test (Saliva) Device Sales by Testing Item
2.4.3.1 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item (2021-2026)
2.4.3.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Testing Item (2021-2026)
2.4.3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Testing Item (2021-2026)
2.5 Drug of Abuse Test (Saliva) Device Segment by Application
2.5.1 Traffic Safety & Roadside Testing
2.5.2 Workplace Testing
2.5.3 Healthcare & Rehabilitation
2.5.4 Others
2.5.5 Drug of Abuse Test (Saliva) Device Sales by Application
2.5.5.1 Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2021-2026)
2.5.5.2 Global Drug of Abuse Test (Saliva) Device Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug of Abuse Test (Saliva) Device Breakdown Data by Company
3.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Company (2021-2026)
3.1.2 Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company (2021-2026)
3.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Company (2021-2026)
3.2.1 Global Drug of Abuse Test (Saliva) Device Revenue by Company (2021-2026)
3.2.2 Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company (2021-2026)
3.3 Global Drug of Abuse Test (Saliva) Device Sale Price by Company
3.4 Key Manufacturers Drug of Abuse Test (Saliva) Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug of Abuse Test (Saliva) Device Product Location Distribution
3.4.2 Players Drug of Abuse Test (Saliva) Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG OF ABUSE TEST (SALIVA) DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Drug of Abuse Test (Saliva) Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug of Abuse Test (Saliva) Device Market Size by Country/Region (2021-2026)
4.2.1 Global Drug of Abuse Test (Saliva) Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug of Abuse Test (Saliva) Device Sales Growth
4.4 APAC Drug of Abuse Test (Saliva) Device Sales Growth
4.5 Europe Drug of Abuse Test (Saliva) Device Sales Growth
4.6 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Growth
5 AMERICAS
5.1 Americas Drug of Abuse Test (Saliva) Device Sales by Country
5.1.1 Americas Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
5.1.2 Americas Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
5.2 Americas Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
5.3 Americas Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug of Abuse Test (Saliva) Device Sales by Region
6.1.1 APAC Drug of Abuse Test (Saliva) Device Sales by Region (2021-2026)
6.1.2 APAC Drug of Abuse Test (Saliva) Device Revenue by Region (2021-2026)
6.2 APAC Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
6.3 APAC Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug of Abuse Test (Saliva) Device by Country
7.1.1 Europe Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
7.1.2 Europe Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
7.2 Europe Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
7.3 Europe Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug of Abuse Test (Saliva) Device by Country
8.1.1 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026)
8.3 Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug of Abuse Test (Saliva) Device
10.3 Manufacturing Process Analysis of Drug of Abuse Test (Saliva) Device
10.4 Industry Chain Structure of Drug of Abuse Test (Saliva) Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug of Abuse Test (Saliva) Device Distributors
11.3 Drug of Abuse Test (Saliva) Device Customer
12 WORLD FORECAST REVIEW FOR DRUG OF ABUSE TEST (SALIVA) DEVICE BY GEOGRAPHIC REGION
12.1 Global Drug of Abuse Test (Saliva) Device Market Size Forecast by Region
12.1.1 Global Drug of Abuse Test (Saliva) Device Forecast by Region (2027-2032)
12.1.2 Global Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug of Abuse Test (Saliva) Device Forecast by Type (2027-2032)
12.7 Global Drug of Abuse Test (Saliva) Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Draeger
13.1.1 Draeger Company Information
13.1.2 Draeger Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.1.3 Draeger Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Draeger Main Business Overview
13.1.5 Draeger Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.2.3 Abbott Laboratories Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Securetec Detektions-Systeme
13.3.1 Securetec Detektions-Systeme Company Information
13.3.2 Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.3.3 Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Securetec Detektions-Systeme Main Business Overview
13.3.5 Securetec Detektions-Systeme Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Oranoxis
13.5.1 Oranoxis Company Information
13.5.2 Oranoxis Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.5.3 Oranoxis Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Oranoxis Main Business Overview
13.5.5 Oranoxis Latest Developments
13.6 Premier Biotech
13.6.1 Premier Biotech Company Information
13.6.2 Premier Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.6.3 Premier Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Premier Biotech Main Business Overview
13.6.5 Premier Biotech Latest Developments
13.7 Healgen Scientific
13.7.1 Healgen Scientific Company Information
13.7.2 Healgen Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.7.3 Healgen Scientific Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Healgen Scientific Main Business Overview
13.7.5 Healgen Scientific Latest Developments
13.8 Lin-Zhi International
13.8.1 Lin-Zhi International Company Information
13.8.2 Lin-Zhi International Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.8.3 Lin-Zhi International Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lin-Zhi International Main Business Overview
13.8.5 Lin-Zhi International Latest Developments
13.9 Neogen Corporation
13.9.1 Neogen Corporation Company Information
13.9.2 Neogen Corporation Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.9.3 Neogen Corporation Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Neogen Corporation Main Business Overview
13.9.5 Neogen Corporation Latest Developments
13.10 UCP Biosciences
13.10.1 UCP Biosciences Company Information
13.10.2 UCP Biosciences Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.10.3 UCP Biosciences Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 UCP Biosciences Main Business Overview
13.10.5 UCP Biosciences Latest Developments
13.11 American Screening Corp
13.11.1 American Screening Corp Company Information
13.11.2 American Screening Corp Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.11.3 American Screening Corp Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 American Screening Corp Main Business Overview
13.11.5 American Screening Corp Latest Developments
13.12 Randox Laboratories
13.12.1 Randox Laboratories Company Information
13.12.2 Randox Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.12.3 Randox Laboratories Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Randox Laboratories Main Business Overview
13.12.5 Randox Laboratories Latest Developments
13.13 AccuBioTech
13.13.1 AccuBioTech Company Information
13.13.2 AccuBioTech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.13.3 AccuBioTech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AccuBioTech Main Business Overview
13.13.5 AccuBioTech Latest Developments
13.14 Assure Tech (Hangzhou)
13.14.1 Assure Tech (Hangzhou) Company Information
13.14.2 Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.14.3 Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Assure Tech (Hangzhou) Main Business Overview
13.14.5 Assure Tech (Hangzhou) Latest Developments
13.15 Wondfo Biotech
13.15.1 Wondfo Biotech Company Information
13.15.2 Wondfo Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.15.3 Wondfo Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Wondfo Biotech Main Business Overview
13.15.5 Wondfo Biotech Latest Developments
13.16 Hangzhou Biotest Biotech
13.16.1 Hangzhou Biotest Biotech Company Information
13.16.2 Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.16.3 Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Hangzhou Biotest Biotech Main Business Overview
13.16.5 Hangzhou Biotest Biotech Latest Developments
13.17 Dochekbio
13.17.1 Dochekbio Company Information
13.17.2 Dochekbio Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.17.3 Dochekbio Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Dochekbio Main Business Overview
13.17.5 Dochekbio Latest Developments
13.18 Venture Biotechnology
13.18.1 Venture Biotechnology Company Information
13.18.2 Venture Biotechnology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.18.3 Venture Biotechnology Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Venture Biotechnology Main Business Overview
13.18.5 Venture Biotechnology Latest Developments
13.19 Prometheus
13.19.1 Prometheus Company Information
13.19.2 Prometheus Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.19.3 Prometheus Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Prometheus Main Business Overview
13.19.5 Prometheus Latest Developments
13.20 Core Technology
13.20.1 Core Technology Company Information
13.20.2 Core Technology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.20.3 Core Technology Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Core Technology Main Business Overview
13.20.5 Core Technology Latest Developments
13.21 Jiangsu Well Biotech Co., Ltd.
13.21.1 Jiangsu Well Biotech Co., Ltd. Company Information
13.21.2 Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.21.3 Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Jiangsu Well Biotech Co., Ltd. Main Business Overview
13.21.5 Jiangsu Well Biotech Co., Ltd. Latest Developments
13.22 Shanghai Chemtron Biotech
13.22.1 Shanghai Chemtron Biotech Company Information
13.22.2 Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.22.3 Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Shanghai Chemtron Biotech Main Business Overview
13.22.5 Shanghai Chemtron Biotech Latest Developments
13.23 Hangzhou Laihe Biotech
13.23.1 Hangzhou Laihe Biotech Company Information
13.23.2 Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
13.23.3 Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Hangzhou Laihe Biotech Main Business Overview
13.23.5 Hangzhou Laihe Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug of Abuse Test (Saliva) Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug of Abuse Test (Saliva) Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Global Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Table 7. Global Drug of Abuse Test (Saliva) Device Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Type (2021-2026)
Table 9. Global Drug of Abuse Test (Saliva) Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Online Sales
Table 11. Major Players of Offline Sales
Table 12. Global Drug of Abuse Test (Saliva) Device Sales by Sales Channels (2021-2026) & (K Units)
Table 13. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels (2021-2026)
Table 14. Global Drug of Abuse Test (Saliva) Device Revenue by Sales Channels (2021-2026) & ($ million)
Table 15. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Sales Channels (2021-2026)
Table 16. Global Drug of Abuse Test (Saliva) Device Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 17. Major Players of Single-Panel
Table 18. Major Players of Multi-Panel
Table 19. Global Drug of Abuse Test (Saliva) Device Sales by Testing Item (2021-2026) & (K Units)
Table 20. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item (2021-2026)
Table 21. Global Drug of Abuse Test (Saliva) Device Revenue by Testing Item (2021-2026) & ($ million)
Table 22. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Testing Item (2021-2026)
Table 23. Global Drug of Abuse Test (Saliva) Device Sale Price by Testing Item (2021-2026) & (US$/Unit)
Table 24. Global Drug of Abuse Test (Saliva) Device Sale by Application (2021-2026) & (K Units)
Table 25. Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2021-2026)
Table 26. Global Drug of Abuse Test (Saliva) Device Revenue by Application (2021-2026) & ($ million)
Table 27. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Application (2021-2026)
Table 28. Global Drug of Abuse Test (Saliva) Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global Drug of Abuse Test (Saliva) Device Sales by Company (2021-2026) & (K Units)
Table 30. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company (2021-2026)
Table 31. Global Drug of Abuse Test (Saliva) Device Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company (2021-2026)
Table 33. Global Drug of Abuse Test (Saliva) Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers Drug of Abuse Test (Saliva) Device Producing Area Distribution and Sales Area
Table 35. Players Drug of Abuse Test (Saliva) Device Products Offered
Table 36. Drug of Abuse Test (Saliva) Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Drug of Abuse Test (Saliva) Device Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Drug of Abuse Test (Saliva) Device Sales Market Share Geographic Region (2021-2026)
Table 41. Global Drug of Abuse Test (Saliva) Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Drug of Abuse Test (Saliva) Device Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2021-2026)
Table 45. Global Drug of Abuse Test (Saliva) Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 48. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Country (2021-2026)
Table 49. Americas Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 51. Americas Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 52. APAC Drug of Abuse Test (Saliva) Device Sales by Region (2021-2026) & (K Units)
Table 53. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Region (2021-2026)
Table 54. APAC Drug of Abuse Test (Saliva) Device Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 56. APAC Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 57. Europe Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 58. Europe Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 60. Europe Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Drug of Abuse Test (Saliva) Device
Table 66. Key Market Challenges & Risks of Drug of Abuse Test (Saliva) Device
Table 67. Key Industry Trends of Drug of Abuse Test (Saliva) Device
Table 68. Drug of Abuse Test (Saliva) Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Drug of Abuse Test (Saliva) Device Distributors List
Table 71. Drug of Abuse Test (Saliva) Device Customer List
Table 72. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Drug of Abuse Test (Saliva) Device Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Drug of Abuse Test (Saliva) Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Draeger Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 87. Draeger Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 88. Draeger Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Draeger Main Business
Table 90. Draeger Latest Developments
Table 91. Abbott Laboratories Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 93. Abbott Laboratories Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Abbott Laboratories Main Business
Table 95. Abbott Laboratories Latest Developments
Table 96. Securetec Detektions-Systeme Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 97. Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 98. Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Securetec Detektions-Systeme Main Business
Table 100. Securetec Detektions-Systeme Latest Developments
Table 101. Thermo Fisher Scientific Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 102. Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 103. Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Thermo Fisher Scientific Main Business
Table 105. Thermo Fisher Scientific Latest Developments
Table 106. Oranoxis Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Oranoxis Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 108. Oranoxis Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Oranoxis Main Business
Table 110. Oranoxis Latest Developments
Table 111. Premier Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 112. Premier Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 113. Premier Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Premier Biotech Main Business
Table 115. Premier Biotech Latest Developments
Table 116. Healgen Scientific Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Healgen Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 118. Healgen Scientific Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Healgen Scientific Main Business
Table 120. Healgen Scientific Latest Developments
Table 121. Lin-Zhi International Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 122. Lin-Zhi International Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 123. Lin-Zhi International Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Lin-Zhi International Main Business
Table 125. Lin-Zhi International Latest Developments
Table 126. Neogen Corporation Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Neogen Corporation Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 128. Neogen Corporation Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Neogen Corporation Main Business
Table 130. Neogen Corporation Latest Developments
Table 131. UCP Biosciences Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 132. UCP Biosciences Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 133. UCP Biosciences Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. UCP Biosciences Main Business
Table 135. UCP Biosciences Latest Developments
Table 136. American Screening Corp Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 137. American Screening Corp Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 138. American Screening Corp Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. American Screening Corp Main Business
Table 140. American Screening Corp Latest Developments
Table 141. Randox Laboratories Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Randox Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 143. Randox Laboratories Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Randox Laboratories Main Business
Table 145. Randox Laboratories Latest Developments
Table 146. AccuBioTech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 147. AccuBioTech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 148. AccuBioTech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. AccuBioTech Main Business
Table 150. AccuBioTech Latest Developments
Table 151. Assure Tech (Hangzhou) Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 152. Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 153. Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Assure Tech (Hangzhou) Main Business
Table 155. Assure Tech (Hangzhou) Latest Developments
Table 156. Wondfo Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 157. Wondfo Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 158. Wondfo Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Wondfo Biotech Main Business
Table 160. Wondfo Biotech Latest Developments
Table 161. Hangzhou Biotest Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 162. Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 163. Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Hangzhou Biotest Biotech Main Business
Table 165. Hangzhou Biotest Biotech Latest Developments
Table 166. Dochekbio Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 167. Dochekbio Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 168. Dochekbio Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 169. Dochekbio Main Business
Table 170. Dochekbio Latest Developments
Table 171. Venture Biotechnology Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 172. Venture Biotechnology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 173. Venture Biotechnology Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 174. Venture Biotechnology Main Business
Table 175. Venture Biotechnology Latest Developments
Table 176. Prometheus Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 177. Prometheus Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 178. Prometheus Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 179. Prometheus Main Business
Table 180. Prometheus Latest Developments
Table 181. Core Technology Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 182. Core Technology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 183. Core Technology Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 184. Core Technology Main Business
Table 185. Core Technology Latest Developments
Table 186. Jiangsu Well Biotech Co., Ltd. Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 187. Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 188. Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 189. Jiangsu Well Biotech Co., Ltd. Main Business
Table 190. Jiangsu Well Biotech Co., Ltd. Latest Developments
Table 191. Shanghai Chemtron Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 192. Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 193. Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 194. Shanghai Chemtron Biotech Main Business
Table 195. Shanghai Chemtron Biotech Latest Developments
Table 196. Hangzhou Laihe Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 197. Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 198. Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 199. Hangzhou Laihe Biotech Main Business
Table 200. Hangzhou Laihe Biotech Latest Developments
Table 1. Drug of Abuse Test (Saliva) Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug of Abuse Test (Saliva) Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Global Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Table 7. Global Drug of Abuse Test (Saliva) Device Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Type (2021-2026)
Table 9. Global Drug of Abuse Test (Saliva) Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Online Sales
Table 11. Major Players of Offline Sales
Table 12. Global Drug of Abuse Test (Saliva) Device Sales by Sales Channels (2021-2026) & (K Units)
Table 13. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels (2021-2026)
Table 14. Global Drug of Abuse Test (Saliva) Device Revenue by Sales Channels (2021-2026) & ($ million)
Table 15. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Sales Channels (2021-2026)
Table 16. Global Drug of Abuse Test (Saliva) Device Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 17. Major Players of Single-Panel
Table 18. Major Players of Multi-Panel
Table 19. Global Drug of Abuse Test (Saliva) Device Sales by Testing Item (2021-2026) & (K Units)
Table 20. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item (2021-2026)
Table 21. Global Drug of Abuse Test (Saliva) Device Revenue by Testing Item (2021-2026) & ($ million)
Table 22. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Testing Item (2021-2026)
Table 23. Global Drug of Abuse Test (Saliva) Device Sale Price by Testing Item (2021-2026) & (US$/Unit)
Table 24. Global Drug of Abuse Test (Saliva) Device Sale by Application (2021-2026) & (K Units)
Table 25. Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2021-2026)
Table 26. Global Drug of Abuse Test (Saliva) Device Revenue by Application (2021-2026) & ($ million)
Table 27. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Application (2021-2026)
Table 28. Global Drug of Abuse Test (Saliva) Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global Drug of Abuse Test (Saliva) Device Sales by Company (2021-2026) & (K Units)
Table 30. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company (2021-2026)
Table 31. Global Drug of Abuse Test (Saliva) Device Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company (2021-2026)
Table 33. Global Drug of Abuse Test (Saliva) Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers Drug of Abuse Test (Saliva) Device Producing Area Distribution and Sales Area
Table 35. Players Drug of Abuse Test (Saliva) Device Products Offered
Table 36. Drug of Abuse Test (Saliva) Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Drug of Abuse Test (Saliva) Device Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Drug of Abuse Test (Saliva) Device Sales Market Share Geographic Region (2021-2026)
Table 41. Global Drug of Abuse Test (Saliva) Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Drug of Abuse Test (Saliva) Device Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2021-2026)
Table 45. Global Drug of Abuse Test (Saliva) Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 48. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Country (2021-2026)
Table 49. Americas Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 51. Americas Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 52. APAC Drug of Abuse Test (Saliva) Device Sales by Region (2021-2026) & (K Units)
Table 53. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Region (2021-2026)
Table 54. APAC Drug of Abuse Test (Saliva) Device Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 56. APAC Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 57. Europe Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 58. Europe Drug of Abuse Test (Saliva) Device Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 60. Europe Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Drug of Abuse Test (Saliva) Device
Table 66. Key Market Challenges & Risks of Drug of Abuse Test (Saliva) Device
Table 67. Key Industry Trends of Drug of Abuse Test (Saliva) Device
Table 68. Drug of Abuse Test (Saliva) Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Drug of Abuse Test (Saliva) Device Distributors List
Table 71. Drug of Abuse Test (Saliva) Device Customer List
Table 72. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Drug of Abuse Test (Saliva) Device Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Drug of Abuse Test (Saliva) Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Drug of Abuse Test (Saliva) Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Drug of Abuse Test (Saliva) Device Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Drug of Abuse Test (Saliva) Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Draeger Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 87. Draeger Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 88. Draeger Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Draeger Main Business
Table 90. Draeger Latest Developments
Table 91. Abbott Laboratories Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 93. Abbott Laboratories Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Abbott Laboratories Main Business
Table 95. Abbott Laboratories Latest Developments
Table 96. Securetec Detektions-Systeme Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 97. Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 98. Securetec Detektions-Systeme Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Securetec Detektions-Systeme Main Business
Table 100. Securetec Detektions-Systeme Latest Developments
Table 101. Thermo Fisher Scientific Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 102. Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 103. Thermo Fisher Scientific Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Thermo Fisher Scientific Main Business
Table 105. Thermo Fisher Scientific Latest Developments
Table 106. Oranoxis Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Oranoxis Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 108. Oranoxis Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Oranoxis Main Business
Table 110. Oranoxis Latest Developments
Table 111. Premier Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 112. Premier Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 113. Premier Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Premier Biotech Main Business
Table 115. Premier Biotech Latest Developments
Table 116. Healgen Scientific Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Healgen Scientific Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 118. Healgen Scientific Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Healgen Scientific Main Business
Table 120. Healgen Scientific Latest Developments
Table 121. Lin-Zhi International Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 122. Lin-Zhi International Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 123. Lin-Zhi International Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Lin-Zhi International Main Business
Table 125. Lin-Zhi International Latest Developments
Table 126. Neogen Corporation Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Neogen Corporation Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 128. Neogen Corporation Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Neogen Corporation Main Business
Table 130. Neogen Corporation Latest Developments
Table 131. UCP Biosciences Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 132. UCP Biosciences Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 133. UCP Biosciences Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. UCP Biosciences Main Business
Table 135. UCP Biosciences Latest Developments
Table 136. American Screening Corp Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 137. American Screening Corp Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 138. American Screening Corp Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. American Screening Corp Main Business
Table 140. American Screening Corp Latest Developments
Table 141. Randox Laboratories Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Randox Laboratories Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 143. Randox Laboratories Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Randox Laboratories Main Business
Table 145. Randox Laboratories Latest Developments
Table 146. AccuBioTech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 147. AccuBioTech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 148. AccuBioTech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. AccuBioTech Main Business
Table 150. AccuBioTech Latest Developments
Table 151. Assure Tech (Hangzhou) Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 152. Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 153. Assure Tech (Hangzhou) Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Assure Tech (Hangzhou) Main Business
Table 155. Assure Tech (Hangzhou) Latest Developments
Table 156. Wondfo Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 157. Wondfo Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 158. Wondfo Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Wondfo Biotech Main Business
Table 160. Wondfo Biotech Latest Developments
Table 161. Hangzhou Biotest Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 162. Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 163. Hangzhou Biotest Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Hangzhou Biotest Biotech Main Business
Table 165. Hangzhou Biotest Biotech Latest Developments
Table 166. Dochekbio Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 167. Dochekbio Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 168. Dochekbio Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 169. Dochekbio Main Business
Table 170. Dochekbio Latest Developments
Table 171. Venture Biotechnology Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 172. Venture Biotechnology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 173. Venture Biotechnology Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 174. Venture Biotechnology Main Business
Table 175. Venture Biotechnology Latest Developments
Table 176. Prometheus Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 177. Prometheus Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 178. Prometheus Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 179. Prometheus Main Business
Table 180. Prometheus Latest Developments
Table 181. Core Technology Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 182. Core Technology Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 183. Core Technology Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 184. Core Technology Main Business
Table 185. Core Technology Latest Developments
Table 186. Jiangsu Well Biotech Co., Ltd. Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 187. Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 188. Jiangsu Well Biotech Co., Ltd. Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 189. Jiangsu Well Biotech Co., Ltd. Main Business
Table 190. Jiangsu Well Biotech Co., Ltd. Latest Developments
Table 191. Shanghai Chemtron Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 192. Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 193. Shanghai Chemtron Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 194. Shanghai Chemtron Biotech Main Business
Table 195. Shanghai Chemtron Biotech Latest Developments
Table 196. Hangzhou Laihe Biotech Basic Information, Drug of Abuse Test (Saliva) Device Manufacturing Base, Sales Area and Its Competitors
Table 197. Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Product Portfolios and Specifications
Table 198. Hangzhou Laihe Biotech Drug of Abuse Test (Saliva) Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 199. Hangzhou Laihe Biotech Main Business
Table 200. Hangzhou Laihe Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug of Abuse Test (Saliva) Device
Figure 2. Drug of Abuse Test (Saliva) Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug of Abuse Test (Saliva) Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug of Abuse Test (Saliva) Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug of Abuse Test (Saliva) Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2025)
Figure 10. Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Consumables
Figure 12. Product Picture of Equipment
Figure 13. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type in 2026
Figure 14. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Online Sales
Figure 16. Product Picture of Offline Sales
Figure 17. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels in 2026
Figure 18. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Sales Channels (2021-2026)
Figure 19. Product Picture of Single-Panel
Figure 20. Product Picture of Multi-Panel
Figure 21. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item in 2026
Figure 22. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Testing Item (2021-2026)
Figure 23. Drug of Abuse Test (Saliva) Device Consumed in Traffic Safety & Roadside Testing
Figure 24. Global Drug of Abuse Test (Saliva) Device Market: Traffic Safety & Roadside Testing (2021-2026) & (K Units)
Figure 25. Drug of Abuse Test (Saliva) Device Consumed in Workplace Testing
Figure 26. Global Drug of Abuse Test (Saliva) Device Market: Workplace Testing (2021-2026) & (K Units)
Figure 27. Drug of Abuse Test (Saliva) Device Consumed in Healthcare & Rehabilitation
Figure 28. Global Drug of Abuse Test (Saliva) Device Market: Healthcare & Rehabilitation (2021-2026) & (K Units)
Figure 29. Drug of Abuse Test (Saliva) Device Consumed in Others
Figure 30. Global Drug of Abuse Test (Saliva) Device Market: Others (2021-2026) & (K Units)
Figure 31. Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2025)
Figure 32. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Application in 2025
Figure 33. Drug of Abuse Test (Saliva) Device Sales by Company in 2025 (K Units)
Figure 34. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company in 2025
Figure 35. Drug of Abuse Test (Saliva) Device Revenue by Company in 2025 ($ millions)
Figure 36. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company in 2025
Figure 37. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 40. Americas Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 42. APAC Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 44. Europe Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Country in 2025
Figure 48. Americas Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 51. United States Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Region in 2025
Figure 56. APAC Drug of Abuse Test (Saliva) Device Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 59. China Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Country in 2025
Figure 67. Europe Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug of Abuse Test (Saliva) Device in 2026
Figure 84. Manufacturing Process Analysis of Drug of Abuse Test (Saliva) Device
Figure 85. Industry Chain Structure of Drug of Abuse Test (Saliva) Device
Figure 86. Channels of Distribution
Figure 87. Global Drug of Abuse Test (Saliva) Device Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug of Abuse Test (Saliva) Device Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug of Abuse Test (Saliva) Device Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drug of Abuse Test (Saliva) Device
Figure 2. Drug of Abuse Test (Saliva) Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug of Abuse Test (Saliva) Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug of Abuse Test (Saliva) Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug of Abuse Test (Saliva) Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2025)
Figure 10. Drug of Abuse Test (Saliva) Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Consumables
Figure 12. Product Picture of Equipment
Figure 13. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Type in 2026
Figure 14. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Online Sales
Figure 16. Product Picture of Offline Sales
Figure 17. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Sales Channels in 2026
Figure 18. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Sales Channels (2021-2026)
Figure 19. Product Picture of Single-Panel
Figure 20. Product Picture of Multi-Panel
Figure 21. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Testing Item in 2026
Figure 22. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Testing Item (2021-2026)
Figure 23. Drug of Abuse Test (Saliva) Device Consumed in Traffic Safety & Roadside Testing
Figure 24. Global Drug of Abuse Test (Saliva) Device Market: Traffic Safety & Roadside Testing (2021-2026) & (K Units)
Figure 25. Drug of Abuse Test (Saliva) Device Consumed in Workplace Testing
Figure 26. Global Drug of Abuse Test (Saliva) Device Market: Workplace Testing (2021-2026) & (K Units)
Figure 27. Drug of Abuse Test (Saliva) Device Consumed in Healthcare & Rehabilitation
Figure 28. Global Drug of Abuse Test (Saliva) Device Market: Healthcare & Rehabilitation (2021-2026) & (K Units)
Figure 29. Drug of Abuse Test (Saliva) Device Consumed in Others
Figure 30. Global Drug of Abuse Test (Saliva) Device Market: Others (2021-2026) & (K Units)
Figure 31. Global Drug of Abuse Test (Saliva) Device Sale Market Share by Application (2025)
Figure 32. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Application in 2025
Figure 33. Drug of Abuse Test (Saliva) Device Sales by Company in 2025 (K Units)
Figure 34. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Company in 2025
Figure 35. Drug of Abuse Test (Saliva) Device Revenue by Company in 2025 ($ millions)
Figure 36. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Company in 2025
Figure 37. Global Drug of Abuse Test (Saliva) Device Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug of Abuse Test (Saliva) Device Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 40. Americas Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 42. APAC Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 44. Europe Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug of Abuse Test (Saliva) Device Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Country in 2025
Figure 48. Americas Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 51. United States Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Region in 2025
Figure 56. APAC Drug of Abuse Test (Saliva) Device Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 59. China Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Country in 2025
Figure 67. Europe Drug of Abuse Test (Saliva) Device Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug of Abuse Test (Saliva) Device Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug of Abuse Test (Saliva) Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug of Abuse Test (Saliva) Device in 2026
Figure 84. Manufacturing Process Analysis of Drug of Abuse Test (Saliva) Device
Figure 85. Industry Chain Structure of Drug of Abuse Test (Saliva) Device
Figure 86. Channels of Distribution
Figure 87. Global Drug of Abuse Test (Saliva) Device Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug of Abuse Test (Saliva) Device Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug of Abuse Test (Saliva) Device Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug of Abuse Test (Saliva) Device Revenue Market Share Forecast by Application (2027-2032)
